New Market Research Report: Healthcare Analytical Testing Services Market - Global Forecast to 2021

Healthcare Analytical Testing Services Market by Type (Stability, Raw Materials, Method Validation, Microbial, Environmental Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, Medical Device Companies) - Global Forecast to 2021

The global healthcare analytical testing services market is estimated to grow at a CAGR of 11.3% from 2016 to 2021, to reach USD 4.13 billion by 2021 from USD 2.42 billion in 2016. Growth in this market is mainly attributed to the growing demand for analytical services for biologics and large-molecule drugs, increasing outsourcing of analytical testing by pharmaceutical companies, rising demand from the nutraceutical industry, and increasing acceptance of the QbD (Quality by Design) approach in pharmaceutical research/manufacturing. In addition, the high quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics market, and presence of a large pool of analytical testing providers are further expected to drive the growth of this market. However, the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry may hinder the growth of this market to a certain extent during the forecast period.
In this report, the healthcare analytical testing services market is segmented on the basis of services, samples, end users, and regions. In 2015, the bioanalytical testing segment accounted for the largest share of the global healthcare analytical testing services market, by type. The large share of this segment can primarily be attributed to the large number of biologic molecules in the pipeline and the growing biopharmaceutical industry. On the basis of samples, the raw materials segment accounted for the largest share of the global healthcare analytical testing services market. In 2015, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the global healthcare analytical testing services market, by end user. This large share for pharmaceutical and biopharmaceutical companies is due to the increased R&D expenditure to develop new drug molecules, growing focus on delivering high-quality products, and rising demand for analytical testing by regulators.
Geographically, North America commanded a major share of the healthcare analytical testing services market in 2015. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the large pool of pharmaceutical and biopharmaceutical companies, government support from both an economic and policy standpoint to drive innovation in life sciences, and rapidly increasing demand for outsourcing of analytical testing.

Full Report Details at
- http://www.fastmr.com/prod/1184216_healthcare_analytical_testing.aspx?afid=301

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Healthcare IT Market - Global Forecast to 2020
- Healthcare Provider Network Management Market - Analysis and Global Forecast to 2020
- In Vitro Diagnostics (IVD) Market - Forecast to 2020
- Healthcare Integration Market - Global Forecast to 2021
- Application Security Market - Global Forecast to 2021